A 43-year-old woman with a history of psoriasis vulgaris, was admitted for nephrotic syndrome started six months before. Renal biopsy revealed membranous glomerulonephritis (MGN). She did not receive any therapy for MGN. Two months later she started therapy for psoriasis with Adalimumab, resulted in disappearance of psoriatic skin lesions with progressive reduction of 24-hours proteinuria. This is the first report of therapeutic efficacy of adalimumab in MGN.

ANTI-TNFa THERAPY IN MEMBRANOUS GLOMERULONEPHRITIS

SANTORO, Domenico;COSTANTINO, Giuseppe;SAVICA, Vincenzo;BELLINGHIERI, Guido
2012

Abstract

A 43-year-old woman with a history of psoriasis vulgaris, was admitted for nephrotic syndrome started six months before. Renal biopsy revealed membranous glomerulonephritis (MGN). She did not receive any therapy for MGN. Two months later she started therapy for psoriasis with Adalimumab, resulted in disappearance of psoriatic skin lesions with progressive reduction of 24-hours proteinuria. This is the first report of therapeutic efficacy of adalimumab in MGN.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/2326027
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact